These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 4360828
1. [Hyperlipoproteinema in chronic arteriosclerotic vascular diseases with occlusions of lower extremities (author's transl)]. Müller G. Angiologica; 1973; 10(5-6):318-25. PubMed ID: 4360828 [No Abstract] [Full Text] [Related]
2. [Blood lipids and glucose tolerance in 100 patients with arteriosclerotic occlusions in the lower extremities]. Beyrer K, May R, Sailer S. Wien Klin Wochenschr; 1968 May 17; 80(20):392-4. PubMed ID: 5728030 [No Abstract] [Full Text] [Related]
3. [Importance of the determination of HDL-cholesterol in the evaluation of arteriopathies of the lower extremities]. Arber F, Darioli R, Monti M, Essinger A. Schweiz Med Wochenschr; 1981 Dec 12; 111(50):1969-71. PubMed ID: 7330649 [No Abstract] [Full Text] [Related]
4. [Prevention of arteriosclerotic heart and vascular diseases]. Siedek H. Wien Med Wochenschr; 1971 Jul 31; 121(30):575-81. PubMed ID: 5564652 [No Abstract] [Full Text] [Related]
5. [Importance of pathogenic factors for the progression of arterial occlusion diseases]. Thiele P. Z Gesamte Inn Med; 1968 Feb 01; 23(3):Suppl:44-6. PubMed ID: 5672424 [No Abstract] [Full Text] [Related]
6. [Dislipoproteinemias as risk factors in cardiovascular diseases: study in patients with chronic ischemic heart disease (author's transl)]. Camejo G, Acquatella H, Lalaguna F, Hirschhaut E, Guinand Baldó A, Burger B, Pérez Rojas M, Aparicio JM, Suárez JA, Pérez Padrón J. Acta Cient Venez; 1977 Feb 01; 28(1):77-81. PubMed ID: 865780 [No Abstract] [Full Text] [Related]
10. [Problems and acquisititions in etipathogenesis of arteriosclerotic disease]. Crepaldi G. Minerva Med; 1973 Apr 14; 64(24):1226-32. PubMed ID: 4707407 [No Abstract] [Full Text] [Related]
11. [Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)]. Schimert G. MMW Munch Med Wochenschr; 1974 Feb 22; 116(8):389-92. PubMed ID: 4208098 [No Abstract] [Full Text] [Related]
12. [Frequency and distribution of types of hyperlipoproteinemia with life-shortening risk factors among ambulant patients (author's transl)]. Mertz DP, Hohneck A. Med Klin; 1975 Jul 11; 70(28-29):1209-13. PubMed ID: 170497 [Abstract] [Full Text] [Related]
15. [Current trends in the therapy of arteriosclerotic disease]. Toscano S. G Clin Med; 1974 Jan 11; 55(1):27-39. PubMed ID: 4369524 [No Abstract] [Full Text] [Related]
16. [Biochemical research on the lipid spectrum in patients with arteriosclerosis, diabetes and obesity]. Verdonk G, Mortelmans R, Vandevivere D. Brux Med; 1972 Mar 11; 52(3):165-6. PubMed ID: 5022749 [No Abstract] [Full Text] [Related]
17. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy. Oki JC. Pharmacotherapy; 1995 Mar 11; 15(3):317-37. PubMed ID: 7667166 [Abstract] [Full Text] [Related]
18. Management of dyslipidemia. Akel MM, Salti I. J Med Liban; 2001 Mar 11; 49(5):274-8. PubMed ID: 12243421 [No Abstract] [Full Text] [Related]